Data / Drug companies / Carbamazepine
Carbamazepine: 52 companies and 154 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Carbamazepine is listed in the FDA National Drug Code Directory by 52 companies, with 154 products in commercial distribution. 143 of the products (92.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet; capsule, extended release, and the newest product started marketing on October 9, 2026.
The request: Get every company that lists carbamazepine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 52
- Products
- 154
- Generic (ANDA) products
- 143 (92.9%)
- Application numbers
- 33
- Routes
- Oral
- Brand names
- Equetro, Carbatrol, Tegretol XR, Tegretol, Carbamazepin
- openFDA record search
- api.fda.gov
Companies that list carbamazepine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Remedyrepack Inc. | 11 | tablet; tablet, extended release | Generic drugs (ANDA) | June 25, 2026 |
| Bryant Ranch Prepack | 9 | capsule, extended release; tablet | Generic drugs (ANDA) | April 21, 2020 |
| Sun Pharmaceutical Industries, Inc. | 7 | tablet, extended release; tablet, chewable | Generic drugs (ANDA) | March 31, 2009 |
| Coupler LLC | 6 | capsule, extended release; tablet | Generic drugs (ANDA) | June 16, 2026 |
| Novartis Pharmaceuticals Corporation | 5 | tablet, extended release; suspension | New drug applications (NDA) | March 25, 1996 |
| Torrent Pharmaceuticals Limited | 5 | tablet, extended release; tablet, chewable | Generic drugs (ANDA) | September 10, 2025 |
| Umedica Laboratories USA Inc. | 5 | tablet, extended release; tablet | Generic drugs (ANDA) | August 20, 2022 |
| Alembic Pharmaceuticals Inc. | 4 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | July 26, 2025 |
| Alembic Pharmaceuticals Limited | 4 | tablet, film coated, extended release; tablet | Generic drugs (ANDA) | July 26, 2025 |
| American Health Packaging | 4 | tablet, extended release; tablet, chewable | Generic drugs (ANDA) | September 29, 2026 |
| Apotex Corp. | 4 | capsule, extended release; tablet | Generic drugs (ANDA) | March 23, 2012 |
| AvPAK | 4 | capsule, extended release; tablet | Generic drugs (ANDA) | October 13, 2025 |
| Golden State Medical Supply, Inc. | 4 | tablet, extended release; tablet | Generic drugs (ANDA) | March 31, 2009 |
| Ajanta Pharma USA Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | March 24, 2023 |
| Ani Pharmaceuticals, Inc. | 3 | capsule, extended release | Generic drugs (ANDA) | April 13, 2026 |
| Ascend Laboratories, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | November 1, 2025 |
| Bostal LLC | 3 | tablet, extended release | Generic drugs (ANDA) | March 31, 2022 |
| Bryant Ranch Prepack | 3 | capsule, extended release; tablet | Generic drugs (ANDA) | March 23, 2012 |
| Epic Pharma, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | June 3, 2024 |
| Ingenus Pharmaceuticals, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | August 1, 2023 |
| Jubilant Cadista Pharmaceuticals Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | August 20, 2022 |
| Major Pharmaceuticals | 3 | tablet; capsule, extended release | Generic drugs (ANDA) | March 23, 2012 |
| NorthStar RxLLC | 3 | tablet, extended release | Generic drugs (ANDA) | February 24, 2026 |
| Rising Pharma Holdings, Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | April 24, 2020 |
| Takeda Pharmaceuticals America, Inc. | 3 | capsule, extended release | New drug applications (NDA) | December 22, 1999 |
| Upsher-Smith Laboratories, LLC | 3 | tablet, extended release | Generic drugs (ANDA) | April 13, 2021 |
| Validus Pharmaceuticals LLC | 3 | capsule, extended release | New drug applications (NDA) | December 10, 2004 |
| Zydus Lifesciences Limited | 3 | tablet, extended release | Generic drugs (ANDA) | March 12, 2019 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet, extended release | Generic drugs (ANDA) | March 12, 2019 |
| A-S Medication Solutions | 2 | tablet | Generic drugs (ANDA) | April 21, 2020 |
| Bryant Ranch Prepack | 2 | tablet, extended release; tablet | Generic drugs (ANDA) | August 20, 2022 |
| Chartwell Governmental & Specialty RX, LLC. | 2 | suspension | Generic drugs (ANDA) | June 5, 2002 |
| Chartwell RX, LLC | 2 | suspension | Generic drugs (ANDA) | June 5, 2002 |
| Golden State Medical Supply, Inc. | 2 | tablet; tablet, chewable | Generic drugs (ANDA) | February 27, 2002 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet; tablet, chewable | Generic drugs (ANDA) | October 24, 2000 |
| Nivagen Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | April 21, 2020 |
| NorthStar Rx LLC | 2 | tablet, extended release | Generic drugs (ANDA) | February 1, 2021 |
| Oryza Pharmaceuticals Inc. | 2 | tablet, extended release | Generic drugs (ANDA) | May 18, 2026 |
| Precision Dose, Inc. | 2 | suspension | Generic drugs (ANDA) | October 9, 2026 |
| Preferred Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | January 8, 2021 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | June 2, 2023 |
| Ani Pharmaceuticals, Inc. | 1 | suspension | Generic drugs (ANDA) | October 6, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | October 3, 1996 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | March 7, 2014 |
| Atlantic Biologicals Corp. | 1 | suspension | Generic drugs (ANDA) | September 20, 2004 |
| Bionpharma Inc. | 1 | tablet | Generic drugs (ANDA) | March 15, 2024 |
| Cardinal Health 107, LLC | 1 | tablet | Generic drugs (ANDA) | September 20, 2010 |
| Direct_Rx | 1 | tablet | Generic drugs (ANDA) | December 1, 2020 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet | Generic drugs (ANDA) | November 1, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | October 3, 1996 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | September 1, 2002 |
| Unichem Pharmaceuticals (USA), Inc. | 1 | tablet | Generic drugs (ANDA) | November 1, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 60 | 39% |
| Tablet | 40 | 26% |
| Capsule, extended release | 27 | 17.5% |
| Tablet, chewable | 11 | 7.1% |
| Suspension | 10 | 6.5% |
| Tablet, film coated, extended release | 6 | 3.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 143 | 92.9% |
| New drug applications (NDA) | 11 | 7.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Mood Stabilizer | 154 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.